This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Reducing monthly expenses is key to effective debt repayment. Learn practical strategies to cut costs and manage your debt.
20,226 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Bitcoin holds in the high-$70k range as AI stocks push higher, leaving investors weighing two very different paths. T...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
SCHD has surged in 2026, outpacing the S&P 500 as dividend-growth funds draw cash-flow hungry investors. Three core E...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
When a well-known investment advisor unloads a large slice of a stock, it sparks questions. This guide breaks down wh...
A major headline sent Goldman Sachs stock popping, tied to reports it could lead SpaceX's mega-IPO. This article brea...
A new industry report shows on-time flight arrivals at their worst since 2014, pushed by higher fuel costs and volati...
Oceaneering International has staged a striking rally, with a fund-backed bet signaling confidence in continued growt...
Two tech giants stand out for investors seeking value in megacap stocks. This guide breaks down strengths, risks, and...
Grab is accelerating its push into physical AI and automated driving, testing robots in Singapore and at its own offi...
Orbital refueling could change the game for long-distance space missions. This deep dive looks at how NASA and Rocket...